Drug Shortage Report for BIAXIN
Report ID | 181319 |
Drug Identification Number | 02146908 |
Brand name | BIAXIN |
Common or Proper name | CLARITHROMYCIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | CLARITHROMYCIN |
Strength(s) | 125MG |
Dosage form(s) | GRANULES FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 55ML, 105ML |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-04-05 |
Actual start date | |
Estimated end date | 2023-06-13 |
Actual end date | 2023-02-02 |
Shortage status | Avoided shortage |
Updated date | 2023-02-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-01-17 | English | Compare |
v2 | 2023-01-17 | French | Compare |
v3 | 2023-01-17 | English | Compare |
v4 | 2023-01-17 | French | Compare |
v5 | 2023-01-23 | English | Compare |
v6 | 2023-01-23 | French | Compare |
v7 | 2023-01-23 | English | Compare |
v8 | 2023-01-23 | French | Compare |
v9 | 2023-02-01 | English | Compare |
v10 | 2023-02-01 | French | Compare |
v11 | 2023-02-06 | English | Compare |
v12 | 2023-02-06 | French | Compare |
Showing 1 to 12 of 12